Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wolff Walsrode is a historic German chemical company based in Walsrode, specializing in the development and production of cellulose-based products for the life sciences and industrial sectors. For many years, it operated as a key subsidiary of Bayer AG, becoming a global leader in the manufacture of cellulose ethers such as methylcellulose and hydroxypropyl methylcellulose (HPMC). These products are critical pharmaceutical excipients used extensively in tablet coatings, controlled-release drug delivery systems, and various food applications. In 2007, the company was acquired by Dow Chemical to form Dow Wolff Cellulosics, and following subsequent industry mergers, it is now part of IFF (International Flavors & Fragrances). The Walsrode site remains a vital manufacturing hub for high-quality polymers used by pharmaceutical companies worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wolf Walsrode.